NCT03682068 2026-02-03
NILE
AstraZeneca
Phase 3 Active not recruiting
Clinical Trials
3 trialsNCT04960709 2025-12-19
VOLGA
AstraZeneca
Phase 3 Active not recruiting
NCT03601455 2025-04-13
Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Active not recruiting